Market Access Why reshoring drug production means embracing continuous man... Recent history should have the pharmaceutical industry questioning some of its fundamental assumptions.
Views & Analysis Digital tools driving innovative clinical trials The COVID-19 pandemic has catalysed significant changes in the way pharma develops drugs, particularly in the cl
Patients From trial design for patients to trial design with patients... At the 2022 Drug Information Association (DIA) annual meeting last week, it was
Events Partner Content Next Generation Lipid-Based Nanoparticles Delivery Summit | ... Harness Safe & Efficacious Lipid-Based Delivery for Novel Therapeutics Beyond RNA & Hepatic Tissue
R&D Understanding the microbiome as an ‘overlooked critical orga... Compared to a ‘critical organ’ that had been largely ignored, companies working to develop microbiome-based therapies believe there is untapped potential in the area.
Events Partner Content Welcome to 1st Rare & Genetic Neurodegenerative Drug Dev... Developing R&G neurodegenerative therapies
News OpenBind unveils its first AI model for drug discovery A research consortium that aims to make the UK a leader in AI-driven drug discovery, OpenBind, has hit its first major milestone.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
